Par profesionales de la salud
Y. Lu, L.G. Karagounis, T.P. Ng, et al.J Gerontol A Biol Sci Med Sci. 2019 Jan 8. doi: 10.1093/gerona/glz001. [Epub ahead of print] The present cross-sectional study characterized the nutritional and metabolic profile of sarcopenia through an extensive exploration of a wide array of blood biomarkers related to muscle protein metabolism and transcriptomic signatures in community-dwelling elderly. |
A. Picca, R. Calvani, C. Leeuwenburgh, et al.Expert Opin Ther Targets. 2019;23(2):153-160 We discuss the evidence that points to mitochondrial dysfunction having a causative role in sarcopenia and the mechanisms involved in the accumulation of damaged mitochondria in the aged muscle. We also discuss the effects of physical exercise on mitochondrial quality control and muscle health in advanced age. |
F. Landi, R. Calvani, A. Picca, et al.Curr Opin Clin Nutr Metab Care. 2019;22(1):37-43 The aim of this review is to discuss recent literature about beta-hydroxy-beta-methylbutyrate (HMB) metabolism, its pharmacokinetics compared with the metabolite leucine, effectiveness of HMB to improve outcomes in older adults, and novel approaches for HMB use. |
R. McCormick and A. VasilakiBiogerontology. 2018;19(6):519-536 As we age, there is an age-related loss in skeletal muscle mass and strength, known as sarcopenia. Sarcopenia results in a decrease in mobility and independence, as well as an increase in the risk of other morbidities and mortality. Sarcopenia is therefore a major socio-economical problem. |
H. Arrieta, G. Hervás, C. Rezola-Pardo, et al.Gerontology. 2018 Nov 21:1-11. doi: 10.1159/000494137. [Epub ahead of print] The aim is to determine the association of serum myostatin concentration with body composition, physical fitness, physical activity level, and frailty in long-term nursing home residents. We also aimed to ascertain the effect of an exercise program on myostatin levels. |
C. Mast, D. Dardevet, I. PapetNutr Res Rev. 2018;31(2):179-192 The present review provides the rationale for the potential pro-sarcopenic effect of paracetamol (acetaminophen; APAP) then recent results concerning the effect of chronic APAP treatment on muscle mass and metabolism are discussed. |



